https://phlox.or.id/index.php/sjdv/issue/feedScientific Journal of Dermatology and Venereology2026-10-20T07:57:33+00:00Phlox Institutephloxinstitute@gmail.comOpen Journal Systems<p><strong>Scientific Journal of Dermatology and Venereology (SJDV)</strong> is an international, peer-reviewed, open-access journal dedicated to dermatology, venereology, and aesthetic medicine, published twice a year (March and September) by Phlox Institute: Indonesian Medical Research Organization. It publishes original research articles, systematic reviews and meta-analyses, case reports and case series, brief communications, clinical images, letters to the editor, and invited editorials, each subject to editorial (desk) evaluation, plagiarism screening, and independent expert peer review in accordance with the standards of COPE, ICMJE, and WAME. As a fully open-access journal, SJDV makes all articles freely available immediately upon publication; authors retain copyright under a Creative Commons Attribution–NonCommercial–ShareAlike 4.0 International (CC BY-NC-SA 4.0) licence, and every article is assigned a DOI to ensure persistent access and citation (e-ISSN 3025-6208).</p> <p> </p>https://phlox.or.id/index.php/sjdv/article/view/359Clinical Spectrum, Histopathological Profiles, and Determinants of Physical Disability Among Patients with Leprosy Reactions: A Five-Year Retrospective Study at a Tertiary Referral Hospital in Surakarta, Indonesia2026-10-13T08:15:42+00:00Wieka Budhiwidayantiw13ka@yahoo.comNurrachmat MuliantoMulianto@gmail.com<p><strong>Background: </strong>Leprosy reactions are acute immune-mediated complications that precipitate severe neuritis and permanent physical disability. Data on reaction phenotypes, comorbidities, and disability determinants in Indonesian tertiary referral centers remain scarce.</p> <p><strong>Objective: </strong>To determine clinical phenotypes, histopathological profiles, comorbidities, and determinants of permanent physical disability among patients with leprosy reactions at Dr. Moewardi Regional General Hospital, Surakarta, Indonesia.</p> <p><strong>Methods: </strong>A five-year retrospective observational study evaluated 45 consecutive patients with leprosy reactions between January 2020 and December 2024. Reaction subtypes (type 1, type 2/ENL, and Lucio phenomenon), comorbidities, and histopathology were analyzed. Bivariate and multivariable binary logistic regression assessed factors associated with permanent physical disability.</p> <p><strong>Results: </strong>Of 45 patients, 77.8% were male. ENL was the most frequent reaction (48.9%), followed by Lucio phenomenon (28.9%) and type 1 reaction (22.2%). Comorbidities occurred in 62.2% of patients, most commonly diabetes mellitus and anemia (11.1% each). Of 24 biopsied patients, 37.5% had Lucio phenomenon. Systemic corticosteroids were used in most patients; 31.8% of ENL patients received methotrexate. Permanent physical disability occurred in 20.0% of patients. In multivariable analysis, Lucio phenomenon (adjusted odds ratio [aOR] = 4.12, 95% CI: 1.18–14.38, p = 0.0264) and anemia (aOR = 3.48, 95% CI: 1.05–11.52, p = 0.0415) were independently associated with disability (area under the curve = 0.824).</p> <p><strong>Conclusion: </strong>Necrotizing Lucio phenomenon and comorbid conditions were frequent in this referral cohort. Lucio phenomenon and concurrent anemia were independently associated with permanent physical disability, supporting early systemic screening and prompt treatment; these findings rest on nine disability events and need confirmation in larger studies.</p>2026-10-18T00:00:00+00:00Copyright (c) https://phlox.or.id/index.php/sjdv/article/view/368Multimorbidity Burden and Specific Clinical Comorbidities in Onychomycosis: A Retrospective Case-Control Study in an Indonesian Tertiary Referral Hospital2026-10-20T07:35:22+00:00Nurrachmat Muliantonurachmat_m@staff.uns.ac.idLabitta Pachira AquairaLabitta.pachira.a@gmail.comHillary Fungestu YoedyantoYoedyanto@gmail.com<p><strong>Background: </strong>Onychomycosis is the most common chronic fungal disease of the nail unit worldwide. Metabolic, vascular and cutaneous disorders are known risk factors. The added effect of a combined comorbidity burden in tropical outpatient populations remains under-evaluated.</p> <p><strong>Objective: </strong>To describe the spectrum of clinical comorbidities and to analyze the association between cumulative comorbidity burden and onychomycosis among outpatients of a tertiary referral hospital in Indonesia.</p> <p><strong>Methods: </strong>This retrospective case-control study took place at the Dermatology Clinic of Dr. Moewardi General Hospital, Surakarta (January 2020 to June 2026). It enrolled 76 patients. There were 38 mycologically confirmed onychomycosis cases (positive 10% potassium hydroxide mount and/or culture) and 38 outpatient controls without onychomycosis. We recorded demographics, obesity, diabetes mellitus, hypertension, venous insufficiency, psoriasis, HIV/immunosuppression, systemic autoimmune disease, tinea pedis and the total comorbidity count. Bivariate analyses used the chi-square and Fisher exact tests. We calculated odds ratios (OR) with 95% confidence intervals (CI).</p> <p><strong>Results: </strong>Tinea pedis (47.4%), obesity (39.5%), hypertension (36.8%), autoimmune disease (31.6%) and diabetes mellitus (31.6%) were the most common comorbidities among cases. Multimorbidity (≥2 comorbidities) was more frequent in cases than in controls (50.0% vs. 15.8%). Patients with no comorbidity were mostly controls (28.9% vs. 7.9%). Cumulative comorbidity burden was associated with onychomycosis (chi-square = 12.01, p = 0.002). The OR for ≥2 vs. 0 comorbidities was 11.61 (95% CI: 2.41–55.94, p = 0.002).</p> <p><strong>Conclusion: </strong>A higher cumulative comorbidity burden was associated with onychomycosis in this single-center case-control study. Management should address coexisting metabolic, vascular and fungal-reservoir conditions alongside antifungal treatment.</p>2026-10-20T00:00:00+00:00Copyright (c) https://phlox.or.id/index.php/sjdv/article/view/370Body Mass Index Categories and Clinical-Epidemiological Profiles of Keloid Scars: A Retrospective Case-Control Study in a Tertiary Referral Hospital in Surakarta, Indonesia2026-10-20T07:57:33+00:00Ammarilis MurastamiMurastami@gmail.comWieka Budhiwidayantiw13ka@yahoo.com<p><strong>Background: </strong>Keloids are refractory fibroproliferative scars that grow beyond the original wound margin. Low-grade systemic inflammation linked to higher body mass index (BMI) has been proposed to promote keloid formation, but the clinical evidence is inconsistent.</p> <p><strong>Objective: </strong>To assess whether Asia-Pacific BMI categories are associated with keloid occurrence and to describe the clinical and epidemiological profile of keloid patients at an Indonesian tertiary referral hospital.</p> <p><strong>Methods: </strong>This retrospective case-control study at Dr. Moewardi General Hospital, Surakarta, Indonesia (January 2022 to December 2025) included 100 subjects: 78 keloid patients (ICD-10 L91.0) and 22 dermatology controls. BMI categories were underweight (<18.5 kg/m²), normal weight (18.5–22.9 kg/m²), overweight (23.0–24.9 kg/m²), and obese (≥25.0 kg/m²). Chi-square tests (Fisher’s exact test where expected counts were small) and multivariable logistic regression were used.</p> <p><strong>Results: </strong>Among 78 keloid patients, 30 (38.5%) were normal weight, 22 (28.2%) obese, 13 (16.7%) underweight, and 13 (16.7%) overweight. BMI category was not significantly associated with keloid occurrence (χ² = 0.666, p = 0.881; obese adjusted OR = 1.412, 95% CI: 0.418–4.770, p = 0.578). Sex (p = 0.244) and age category (p = 0.305) did not differ significantly. The anterior trunk was the most common site (47.4%). Wounds (29.5%) and surgical scars (28.2%) were the main triggers; intralesional triamcinolone acetonide was the main treatment (87.2%).</p> <p><strong>Conclusion: </strong>BMI category was not significantly associated with keloid occurrence, but the small control group (n = 22) limits power. Keloids were most often found at the anterior trunk and after skin injury.</p>2026-10-21T00:00:00+00:00Copyright (c)